Shanghai Haohai discloses H shares repurchase activity

Shanghai Haohai Biological Technology Co., Ltd. submitted a Next Day Disclosure Return on December 4, 2025, detailing changes in its H shares and repurchases. The company reported an opening balance of 38,529,240 H shares as of December 3, 2025, which remained unchanged as of the closing balance date of December 4, 2025.

The disclosure also outlined significant share repurchase activities, with a total of 64,000 H shares repurchased on December 4, 2025, on the Exchange. The highest repurchase price per share was HK$27.34, and the lowest was HK$27.1, resulting in an aggregate price paid of HK$1,742,418 for these repurchases. These repurchased shares are currently held and not yet cancelled.

Furthermore, the company provided a comprehensive list of repurchases made between September 15, 2025, and December 4, 2025. The total number of shares authorized for repurchase under the mandate granted on June 10, 2025, is 3,914,184. As of the date of the resolution granting the repurchase mandate, the repurchases represent 5.1594% of the issued shares. The moratorium period for issuing new shares or transferring treasury shares after these repurchases extends up to January 3, 2026.